GGrantIndex
Sort

50,496 grants matching lung cancer

Western New York Cancer Coalition (WNYC2) Center to Reduce Disparities

$734,017
Willie Underwood · Roswell Park Cancer Institute Corp · U54 · FY2014 · CA

Vascular, Pulmonary and Renal Injury

$733,947
Michael A Gimbrone · Brigham And Women'S Hospital · T32 · FY2012 · HL

Vascular, Pulmonary and Renal Injury

$733,947
Michael A Gimbrone · Brigham And Women'S Hospital · T32 · FY2013 · HL

Case-Control Study of Pancreas Cancer Etiologic Factors

$733,890
Harvey A Risch · Yale University · R01 · FY2007 · CA

CANCER PREVENTION AND CONTROL TRAINING GRANT

$733,877
University Of Arizona · R25 · FY2002 · CA

The Women's Health Study: Infrastructure Support for Continued Cohort Follow-up

$733,834
Julie E Buring · Brigham And Women'S Hospital · UM1 · FY2014 · CA

Biomarkers of Human Lung Cancer

$733,746
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Inflammation and Cancer

$733,746
Curtis Harris · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA

Counseling older Americans to control hypertension (COACH)

$733,735
Gbenga Godwin Ogedegbe · Columbia University Health Sciences · P60 · FY2011 · MD

Comparative Effectiveness of Surgery vs Stereotactic Radiation Therapy for Stage I Lung Cancer

$733,612
Benjamin D Kozower · Washington University · R01 · FY2022 · CA

New Therapies to Restore Vascular Integrity During Sepsis

$733,546
Andrew Scott Weyrich · University Of Utah · R01 · FY2017 · HL

Prevention of Hepatocellular Carcinoma (HCC) Associated with Non-Alcoholic Steatohepatitis (NASH)

$733,441
Laura Beretta · University Of Tx Md Anderson Can Ctr · N01 · FY2018 · CA

Transformed Epithelial Cells and Activated Fibroblasts in the Esopheageal Tumor M

$733,309
Anil K Rustgi · University Of Pennsylvania · P01 · FY2011 · CA

Perfluoroalkyl Substances (PFASs) and Liver Cancer Risk in the United States

$733,285
Xuehong Zhang · Yale University · U01 · FY2025 · CA

Predictors and Consequences of Combustible Cigarette Smokers' Switch to Standardized Research E-Cigarettes

$733,230
Robin J Mermelstein · University Of Illinois At Chicago · U01 · FY2017 · DA

Mechanism of Action of a Novel Golgi-Targeted Anti-Cancer Agent

$733,096
Seth J Field · Case Western Reserve University · R01 · FY2021 · CA

Risk prediction and longitudinal assessment of cardiotoxicity and functional capacity trajectory in NSCLC patients

$733,032
Zhongxing Liao · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · HL

Cellular Basis Of Action Of Gastrointestinal Peptides/Growth factors

$733,009
Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Characterization And Pharmacology Of Receptors For Gastrointestinal Peptides

$733,009
Robert Jensen · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK

Late Effects Prediction using Clinical Phenotypes and Whole Genome Sequencing

$732,780
Yutaka Yasui · St. Jude Children'S Research Hospital · R01 · FY2017 · CA

The COVID-19 and Cancer Consortium (CCC19) Registry

$732,687
Jeremy Lyle Warner · Rhode Island Hospital · U01 · FY2024 · CA

Stationary Digital Tomosynthesis for Transbronchial Biopsy Guidance

$732,676
Yueh Z Lee · Univ Of North Carolina Chapel Hill · R01 · FY2020 · EB

LKB1 tumor suppressor and human cancer

$732,590
Diego H Castrillon · Ut Southwestern Medical Center · U01 · FY2013 · CA

Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data

$732,586
Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2021 · CA

Clinical Sample

$732,580
Peter Kuhn · Scripps Research Institute, The · U54 · FY2013 · CA